Lingshi Tan is the founder of dMed. dMed has raised $214M in total funding. Latest round: Series B. Based in Shanghai, China.
Lingshi Tan is the Founder and CEO of dMed, a global full-service clinical contract research organization (CRO) that provides industry solutions to pharmaceutical and medical device companies. dMed has raised nearly $50 million in Series B financing, led by Vivo Capital, with participation from Legend Capital, Qiming Venture Partners, and Lilly Asia Ventures. Previously, Tan founded and served as the General Manager of Pfizer's Global R&D Center in China, which grew to over 1000 professionals under his 11-year leadership. He retired from Pfizer after 20 years to found dMed in August 2016.
Full founder directory · Investor directory · Company funding database · Fundraising library